Biohaven Pharma (BHVN) Announces Preliminary 4Q2020 Net Product Revenue For NURTEC ODT
Go back to Biohaven Pharma (BHVN) Announces Preliminary 4Q2020 Net Product Revenue For NURTEC ODT(NYSE: BHVN) | Delayed: 39.61 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $39.61 | 52 Week High | $ | |||
Open | $39.61 | 52 Week Low | $ | |||
Day High | $39.61 | P/E | N/A | |||
Day Low | $39.61 | EPS | $ | |||
Volume | 2,050 |